Please provide your email address to receive an email when new articles are posted on . Cardiovascular Systems Inc. announced a recall of its embolic protection device due to complaints of filter ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...
TAVR is a less invasive cardiac procedure that treats patients with severe aortic stenosis without open heart surgery. While TAVR represents a major advance for patients, it carries a small but ...
The recall was initiated following reports of 9 device malfunctions. Cardiovascular Systems Inc. has issued a voluntary recall of unused WIRION ® Embolic Protection systems due to complaints of filter ...
Less than a year after debuting its Wirion embolic protection system, Cardiovascular Systems is recalling all of the devices manufactured and distributed between January and November 2021. The Wirion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results